Clinical Trial Update: A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluated vitamin D as a preventive treatment for migraine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Aalborg University | Conditions: Migraine According to International Headache Society (IHS) Criteria (ICHD-II) | Phase 3 | Status: COMPLETED